But this problem is only the latest in an expanding list of challenges with the technology, including genomic havoc and concerns about cancer. Meanwhile, an appeals court has struck down a challenge to a CRISPR patent ruling.

from Kaiser Health News https://ift.tt/2CLcJDi

Related Posts:

0 comments:

Post a Comment

Popular Posts